U.S., Nov. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07913542) titled 'N-Acetylcysteine for Bipolar and Alcohol Use Disorders' on Oct. 27.
Brief Summary: This study will evaluate N-acetylcysteine (NAC) in adults with bipolar disorder and alcohol use disorder. Participants will be randomly assigned to receive NAC or matched placebo for 28 days. The study includes five visits and three MRI brain imaging scans. Questionnaires, clinical interviews, alcohol and drug assessments, laboratory testing, and monitoring for possible side effects will be completed during study visits.
Study Start Date: Jan. 01, 2027
Study Type: INTERVENTIONAL
Condition:
Bipolar Disorder
Alcohol Use Disorder
Intervention:
DRUG:...